3 Overlooked Trends Shaping 2026
InvestorPlace
|
January 11, 2026 at 05:17 PM UTC
Bullish
76% Confidence
Unanimous Agreement
Read Original Article
Key Points
- Rate cuts: Wall Street expects only two Fed rate cuts in 2026, but White House rhetoric and Trump's dovish Fed chair preference suggest more cuts likely; Rocket Companies (RKT) positioned to benefit from mortgage refinancing wave if rates fall below 6%
- Gene editing: FDA introduced accelerated approval pathway in November allowing gene-editing therapies to skip large randomized trials; Crispr Therapeutics (CRSP) revenues projected to surge from $9.4M in 2025 to $112M in 2026 and potentially $1B by 2030
- Domestic security: Evolv Technologies (EVLV) produces AI-powered weapon detection gates for public spaces; company has improved after 2024 management changes and is DHS-approved, with Wall Street underestimating 2026 growth above 15% consensus
AI Summary
Market Summary: 3 Overlooked Trends Shaping 2026
Key Thesis
InvestorPlace analyst Tom Yeung warns that "hindsight investing"—betting on 2024-2025's AI and tech winners—may fail in 2026. Senior Analyst Louis Navellier has turned cautiously bearish, predicting a potential "hidden crash" as trillion-dollar tech giants show collapsing earnings momentum.
Three Overlooked Investment Trends
1. Accelerated Rate Cuts
- Wall Street expects only two rate cuts in 2026, but betting markets project 3-4 cuts
- President Trump seeks faster rate reductions, calling Fed Chair Powell "TOO LATE"
- Pick: Rocket Cos. Inc. (RKT) – A-rated mortgage refinancing leader
- Trump ordered $200 billion mortgage bond purchase to lower borrowing costs
- Mortgage rates could fall below 6% if Fed cuts rates below 2.75%
2. Gene Editing Technologies
- FDA unveiled accelerated approval pathway in November 2025, allowing companies to skip large randomized trials
- Pick: Crispr Therapeutics AG (CRSP) – B-rated, founded by CRISPR/Cas9 inventors
- Revenue projections: $9.4M (2025) → $112M (2026) → $273M (2027) → $1B (2030)
- First sickle cell gene therapy recently approved; Trump administration supportive
3. Domestic Security Technology
- Pick: Evolv Technologies Holdings Inc. (EVLV) – B-rated weapon detection systems
- Uses AI-powered, unintrusive screening gates for stadiums, schools, and public spaces
- DHS-approved; pursuing airport approvals
- New CEO implemented subscription model after 2024 scandal
- Wall Street forecasts 15% growth; analyst expects outperformance
Market Implications
Yeung draws parallels to previous crashes (1987, 2000, 2008), warning that lagging indicators mask underlying weaknesses in current AI-driven trends.
Model Analysis Breakdown
| Model | Sentiment | Confidence |
|---|---|---|
| GPT-5-mini | Bullish | 75% |
| Claude 4.5 Haiku | Bullish | 68% |
| Gemini 2.5 Flash | Bullish | 85% |
| Consensus | Bullish | 76% |